Delivery Order SPE2DB20D3101-SPE2DB23FRYX4

Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,125.70 firm fixed-price delivery order is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,261.35, is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of September 22, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,279.49, is a Delivery Order for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has an ultimate completion date of January 30, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,444.13, is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The firm-fixed-price delivery order, valued at $2,617.68, has an ultimate completion date of February 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,290.04, is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. This is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract has a Ceiling Value of $1,476.42 and an Ultimate Completion Date of November 28, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract has a ceiling value of $1,063.73 and a completion date of August 6, 2024. It is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,664.20, is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract has a period of performance through February 7, 2024 and uses a Firm Fixed Price pricing type. This award is a Delivery Order under Amerisourcebergen's existing $999,999,999 Indefinite...
This federal contract award, valued at $1,971.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, to support federal healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRYX4
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a ceiling value of $2,998.89 and a completion date of September 27, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and the contract is funded by the Defense Logistics Agency, a defense agency responsible for providing supplies and services to the U.S. military.

Generated 2/27/25, 1:24 PM